LA JOLLA PHARMACEUTICAL CO Finite-Lived Intangible Assets, Net
LA JOLLA PHARMACEUTICAL CO had Finite-Lived Intangible Assets, Net of $12.54 million as of 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2022-08-15
- 2022-06-30: Finite-Lived Intangible Assets, Net $12.54M.
- 2022-03-31: Finite-Lived Intangible Assets, Net $12.93M.
- 2021-12-31: Finite-Lived Intangible Assets, Net $13.32M.
- 2021-09-30: Finite-Lived Intangible Assets, Net $13.71M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2022-06-30 | $12.54M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $12.93M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $13.32M 10-Q · filed 2022-08-15 |
| 2021-09-30 | $13.71M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $14.10M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $14.48M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $14.87M 10-K · filed 2022-03-09 |
| 2020-09-30 | $15.26M 10-Q · filed 2020-11-09 |